Lanzhou Foci Pharmaceutical rose by the limit in the afternoon, and Chongqing Pharscin Pharmaceutical, Zhejiang Wecome Pharmaceutical, Changjiang Pharmaceutical Group, and Jianmin Pharmaceutical Group all rose by more than 5%. Xinguang Pharmaceutical, Panlong Pharmaceutical, Datang Pharmaceutical, and Jiangxi Wannianqing Cement followed suit. Huaan's research reports indicate that the concerns about the price policy and centralized procurement have limited impact on most TCM companies, and the latest standardization policy for TCM shows the importance placed on TCM by top-level design. The second quarter performance is expected to accelerate the reversal under the low base, and the valuation cost-effectiveness of the TCM sector is highlighted.
中药股震荡走强 佛慈制药午后涨停
Traditional Chinese medicine stocks are volatile and strong. Lanzhou Foci Pharmaceuticals hit the limit up in the afternoon.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated